Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy

Reimann H, Kremer A, Blumenberg V, Schmidt K, Aigner M, Kremer A, Tenbusch M, Bruns H, Harrer T, Schett G, Müller F, Mackensen A, Subklewe M, Völkl S (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Blood American Society of Hematology

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Pages Range: 10279-10280

Conference Proceedings Title: BLOOD

DOI: 10.1182/blood-2022-165968

Authors with CRIS profile

Hannah Reimann Department of Medicine 5 – Haematology and Oncology Anita Kremer Department of Medicine 5 – Haematology and Oncology Matthias Tenbusch Professur für Genbasierte Immunisierungsverfahren Heiko Bruns Department of Medicine 5 – Haematology and Oncology Thomas Harrer Professur für Innere Medizin mit dem Schwerpunkt Immundefizienz Georg Schett Lehrstuhl für Innere Medizin III Fabian Müller Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V Simon Völkl Department of Medicine 5 – Haematology and Oncology

Involved external institutions

LMU Klinikum DE Germany (DE) Universitätsspital Zürich (USZ) CH Switzerland (CH) Ludwig-Maximilians-Universität (LMU) DE Germany (DE)

How to cite

APA:

Reimann, H., Kremer, A., Blumenberg, V., Schmidt, K., Aigner, M., Kremer, A.,... Völkl, S. (2022). Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy. In BLOOD (pp. 10279-10280). WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Reimann, Hannah, et al. "Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2022. 10279-10280.

BibTeX: Download